Basit öğe kaydını göster

dc.contributor.authorERDEN, Sacide
dc.contributor.authorGELINCIK, Aslı
dc.contributor.authorGENC, S
dc.contributor.authorÇolakoğlu, B
dc.contributor.authorBuyukozturk, Suna
dc.contributor.authorKOCAK, H
dc.contributor.authorONERIYIDOGAN, Y
dc.contributor.authorDAI, M
dc.date.accessioned2021-03-06T12:38:37Z
dc.date.available2021-03-06T12:38:37Z
dc.date.issued2004
dc.identifier.citationBuyukozturk S., GELINCIK A., GENC S., KOCAK H., ONERIYIDOGAN Y., ERDEN S., DAI M., Çolakoğlu B., "Acute phase reactants in allergic airway disease", TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, cilt.204, ss.209-213, 2004
dc.identifier.issn0040-8727
dc.identifier.otherav_f4dedaa9-81af-4318-84c0-f412b6c78bdf
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/160496
dc.identifier.urihttps://doi.org/10.1620/tjem.204.209
dc.description.abstractAcute phase reactants have been implicated for their involvement as proinflammatory molecules in various inflammatory diseases. However, little is known regarding their role in the allergic airway disease. The aim of the present study was to examine the blood concentrations of three acute-phase proteins, namely C-reactive protein (CRP), serum amyloid A (SAA) and fibrinogen in patients with allergic rhinitis and asthma. Three study groups include: non-smoker allergic rhinitis (n = 50), non-smoker asthma (n = 20), and non-allergic, non-smoker healthy control subjects (n = 20). Patients who have had recent upper or lower respiratory tract infection and trauma, any rheumatological illnesses, malignancy or obesity were excluded. Blood samples were obtained from all the patients and control subjects and were analyzed for serum CRP, SAA and plasma fibrinogen. The mean CRP and fibrinogen values in the rhinitis and asthma groups were not significantly different when compared to the control group. However, the mean SAA levels of both groups were found to be significantly higher than those of the control group (p = 0.002 for rhinitis, p = 0.02 for asthma). There was no significant correlation between the FEV1 values and the levels of the serum markers. This study demonstrates that acute phase reactant SAA rises in patients with allergic rhinitis and patients with asthma. We therefore suggest that SAA may have a role in the inflammatory airway disease. (C) 2004 Tohoku University Medical Press.
dc.language.isoeng
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleAcute phase reactants in allergic airway disease
dc.typeMakale
dc.relation.journalTOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume204
dc.identifier.issue3
dc.identifier.startpage209
dc.identifier.endpage213
dc.contributor.firstauthorID7631


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster